Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,805.30
-13 (-0.71%)
BSENSE

Dec 05

BSE+NSE Vol: 18.14 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
29,065.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
29,065.91
Raw Material Cost
6,449.10
6,904.33
7,777.57
7,049.12
6,153.13
5,515.23
5,782.70
Purchase of Finished goods
4,147.95
3,466.15
3,571.50
3,410.03
3,175.17
3,414.37
2,519.38
(Increase) / Decrease In Stocks
150.31
292.13
-686.91
-107.61
-638.22
300.85
-433.11
Employee Cost
9,973.12
9,429.06
8,296.03
7,300.83
6,862.23
6,362.35
5,967.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
1,912.87
Other Expenses
16,586.27
15,382.05
13,280.70
10,604.40
9,454.46
10,254.94
7,009.39
Total Expenditure (Excl Depreciation)
37,306.75
35,473.72
32,238.89
28,256.77
25,006.77
25,847.74
22,758.32
Operating Profit (PBDIT) excl Other Income
15,271.69
13,023.13
11,646.79
10,397.72
8,491.37
6,989.76
6,307.59
Other Income
1,965.04
1,354.19
634.52
921.51
835.52
635.98
1,025.49
Operating Profit (PBDIT)
17,236.73
14,377.32
12,281.31
11,319.23
9,326.89
7,625.74
7,333.08
Interest
231.36
238.47
172.00
127.35
141.43
302.73
555.25
Exceptional Items
-677.85
-494.32
-171.45
-4,566.82
-4,306.14
-260.64
-1,214.38
Gross Profit (PBDT)
16,327.52
13,644.53
11,937.86
6,625.06
4,879.32
7,062.37
5,563.45
Depreciation
2,575.39
2,556.64
2,529.43
2,143.74
2,079.95
2,052.78
1,753.25
Profit Before Tax
13,752.13
11,087.89
9,408.43
4,481.32
2,799.37
5,009.59
3,810.20
Tax
2,772.03
1,439.45
847.59
1,075.50
514.69
822.80
600.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
3,209.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
3,209.32
Share in Profit of Associates
-15.35
-38.41
-47.90
-16.54
-12.33
-14.83
-1.46
Minority Interest
-35.71
-33.65
-39.36
-116.55
631.47
-407.03
-542.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10,929.04
9,576.38
8,473.58
3,272.73
2,903.82
3,764.93
2,665.42
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
71,978.09
63,426.82
55,755.45
47,771.29
46,222.85
45,024.52
41,169.13
Earnings per share (EPS)
45.55
39.91
35.32
13.64
12.1
15.69
11.11
Diluted Earnings per share
45.6
39.9
35.3
13.6
12.1
15.69
11.11
Operating Profit Margin (Excl OI)
29.35%
27.27%
26.91%
27.06%
25.55%
21.62%
21.99%
Gross Profit Margin
31.37%
28.57%
27.58%
17.24%
14.68%
21.85%
19.39%
PAT Margin
21.1%
20.2%
19.78%
8.86%
6.87%
12.95%
11.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.42% vs 10.51% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 14.12% vs 13.01% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 17.27% vs 11.82% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -2.98% vs 38.65% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
52,578.44
9,360.00
43,218.44
461.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
52,578.44
9,360.00
43,218.44
461.74%
Raw Material Cost
6,449.10
3,821.00
2,628.10
68.78%
Purchase of Finished goods
4,147.95
0.00
4,147.95
(Increase) / Decrease In Stocks
150.31
-96.00
246.31
256.57%
Employee Cost
9,973.12
1,243.00
8,730.12
702.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
16,586.27
1,424.00
15,162.27
1,064.77%
Total Expenditure (Excl Depreciation)
37,306.75
6,392.00
30,914.75
483.65%
Operating Profit (PBDIT) excl Other Income
15,271.69
2,968.00
12,303.69
414.54%
Other Income
1,965.04
352.00
1,613.04
458.25%
Operating Profit (PBDIT)
17,236.73
3,320.00
13,916.73
419.18%
Interest
231.36
2.00
229.36
11,468.00%
Exceptional Items
-677.85
0.00
-677.85
Gross Profit (PBDT)
16,327.52
3,318.00
13,009.52
392.09%
Depreciation
2,575.39
402.00
2,173.39
540.64%
Profit Before Tax
13,752.13
2,916.00
10,836.13
371.61%
Tax
2,772.03
725.00
2,047.03
282.35%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10,980.10
2,191.00
8,789.10
401.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10,980.10
2,191.00
8,789.10
401.15%
Share in Profit of Associates
-15.35
0.00
-15.35
Minority Interest
-35.71
0.00
-35.71
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10,929.04
2,191.00
8,738.04
398.82%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
71,978.09
14,916.00
57,062.09
382.56%
Earnings per share (EPS)
45.55
82.68
-37.13
-44.91%
Diluted Earnings per share
45.60
82.53
-36.93
-44.75%
Operating Profit Margin (Excl OI)
29.35%
31.71%
0.00
-2.36%
Gross Profit Margin
31.37%
35.45%
0.00
-4.08%
PAT Margin
21.10%
23.41%
0.00
-2.31%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 52,578.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.42% vs 10.51% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 10,929.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.12% vs 13.01% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15,271.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.27% vs 11.82% in Mar 2024

Annual - Interest
Interest 231.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.98% vs 38.65% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.35%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024